nanoChannel Drug Delivery Implant

  1. Ferrati S, Fine D, You J, et al. Leveraging nanochannels for universal, zero-order drug delivery in vivo. J Control Release. 2013. doi:10.1016/j.jconrel.2013.09.028.

  2. Nicolov E, Ferrati S, Goodall R, et al. Nanotechnology-Based Implant for Long Term Testosterone Replacement. J Urol â. 2014;191(4S).

  3. Ferrati S, Nicolov E, Zabre E, et al. The Nanochannel Delivery System for Constant Testosterone Replacement Therapy. J Sex Med. 2015;Epub ahead. doi:10.1111/jsm.12897.

  4. Ferrati S, Nicolov E, Bansal S, et al. Delivering Enhanced Testosterone Replacement Therapy through Nanochannels. Adv Healthc Mater. 2015. doi:10.1002/adhm.201400348.

  5. Ferrati S, Nicolov E, Bansal S, Hosali S, Landis M, Grattoni A. Docetaxel/2-Hydroxypropyl β-Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System. Curr Drug Targets. 2015;Epub ahead. 

nanoPorous Silica Diagnostic Tool

  1. Ye H, Bouamrani A, Tasciotti E, Li L, Liu X, Ferrari M. Tailoring of the Nanotexture of Mesoporous Silica Films and their Functionalized Derivatives for Selectively Harvesting Low Molecular Weight Protein. ACS Nano. 2010;4(1):997-1003. doi:10.1021/nn901322d.

  2. Bouamrani A, Hu Y, Tasciotti E, et al. Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome. Proteomics. 2010;10(3):496-505. doi:10.1002/pmic.200900346.

  3. Hu Y, Gopal A, Lin K, et al. Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip. Biomicrofluidics. 2011;5(1):1-7. doi:10.1063/1.3528237.

  4. Fan J, Niu S, Dong A, et al. Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluids. Nanomediicine. 2014;10(5):879-888.

  5. Deng Z, Li Y, Fan J, et al. Circulating Peptidome to Indicate the Tumor-resident Proteolysis. Sci Rep. 2015;5:9327. doi:10.1038/srep09327.

Technology Reviews & Perspectives

  1. Liotta L a, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature. 2003;425(6961):905. doi:10.1038/425905a.

  2. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5(3):161-171. doi:10.1038/nrc1566.


The three technology platforms have been extensively published in peer-reviewed technology and clinical journals.  In fact, over 200 manuscripts can be found on PubMed.

Please contact NMS for assistance in obtaining publications.